Ticker Details
Amarin Corporation plc Amarin Corp PLC is a biopharmaceutical company with expertise in lipid science. The company is engaged in commercialization and development of therapeutics to improve cardiovascular health.
IPO Date:	April 1, 1993
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$287.9M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.19 | 4.00%
Avg Daily Range (30 D):	$0.20 | 1.43%
Avg Daily Range (90 D):	$0.25 | 1.71%

Institutional Daily Volume
Avg Daily Volume:	2.69M
Avg Daily Volume (30 D):	.07M
Avg Daily Volume (90 D):	.07M

Trade Size
Avg Trade Size (Sh.):	308
Avg Trade Size (Sh.) (30 D):	91
Avg Trade Size (Sh.) (90 D):	82

Institutional Trades
Total Institutional Trades:	4,738
Avg Institutional Trade:	$1.27M
Avg Institutional Trade (30 D):	$3.88M
Avg Institutional Trade (90 D):	$3.88M
Avg Institutional Trade Volume:	.01M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$1.48M
Avg Closing Trade (30 D):	$1.18M
Avg Closing Trade (90 D):	$1.18M
Avg Closing Volume:	6.75K

News

Jun 4, 2026 @ 9:39 PM Hikma comments on Supreme Court of the United Stat... Source: Prnewswire

Mar 7, 2026 @ 6:15 AM Here's Why I Wouldn't Touch Amarin With a 10â€â... Source: Reuben Gregg Brewer

Nov 11, 2025 @ 7:27 PM RECORDATI FIRST NINE MONTHS 2025 RESULTS: REVENUE ... Source: Recordati S.P.A.

Nov 9, 2025 @ 9:15 PM New REDUCE-IT® Aspirin Analysis Presented at AH... Source: Amarin Corporation

Oct 14, 2025 @ 12:00 PM Amarin and HLS Therapeutics Collaborate on Present... Source: Amarin Corporation

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.06	$-.02	$-.03
Diluted EPS	$-.06	$-.02	$-.03
Revenue	$186.23M	$42.21M	$45.13M
Gross Profit	$78.14M	$14.99M	$17.77M
Net Income / Loss	$-27.12M	$-7.65M	$-10.51M
Operating Income / Loss	$-40.77M	$-12.01M	$-11.33M
Cost of Revenue	$108.1M	$27.22M	$27.36M
Net Cash Flow	$-4.42M	$12.5M	$-3.6M
PE Ratio

Splits
Apr 11, 2025	1:20
Jan 18, 2008	1:10